Current Antipsychotics

Editors:

ISBN: 978-3-642-25760-5 (Print) 978-3-642-25761-2 (Online)

Table of contents (14 chapters)

  1. Front Matter

    Pages i-x

  2. No Access

    Book Chapter

    Pages 1-26

    The Dopamine Dysfunction in Schizophrenia Revisited: New Insights into Topography and Course

  3. No Access

    Book Chapter

    Pages 27-52

    Role of Dopamine D2 Receptors for Antipsychotic Activity

  4. No Access

    Book Chapter

    Pages 53-86

    Dopamine Receptor Signaling and Current and Future Antipsychotic Drugs

  5. No Access

    Book Chapter

    Pages 87-124

    Serotonergic Mechanisms as Targets for Existing and Novel Antipsychotics

  6. No Access

    Book Chapter

    Pages 125-134

    Managing the Prodrome of Schizophrenia

  7. No Access

    Book Chapter

    Pages 135-164

    Metabolic Consequences of Antipsychotic Therapy: Preclinical and Clinical Perspectives on Diabetes, Diabetic Ketoacidosis, and Obesity

  8. No Access

    Book Chapter

    Pages 165-185

    Medical Needs in the Treatment of Psychotic Disorders

  9. No Access

    Book Chapter

    Pages 187-212

    Antipsychotics in the Treatment of Bipolar Disorder

  10. No Access

    Book Chapter

    Pages 213-239

    The Pharmacogenetics of Antipsychotic Treatment

  11. No Access

    Book Chapter

    Pages 241-265

    Interactions and Monitoring of Antipsychotic Drugs

  12. No Access

    Book Chapter

    Pages 267-298

    Delivery Systems and Dosing for Antipsychotics

  13. No Access

    Book Chapter

    Pages 299-337

    Imaging as Tool to Investigate Psychoses and Antipsychotics

  14. No Access

    Book Chapter

    Pages 339-360

    Biomarkers for Antipsychotic Therapies

  15. No Access

    Book Chapter

    Pages 361-406

    Behavioral Animal Models of Antipsychotic Drug Actions

  16. Back Matter

    Pages 407-416